On September 11, 2026, Zhisheng Chen sold 1.20 million shares of WUXI BIO (02269) on the SEHK open market at an average of HKD 49.1359 per share, involving about HKD 58.96 million. The shares were underlying shares pursuant to options exercised by Dr. Chen under the Pre-IPO Share Option Scheme of the Company, sold for the purposes of satisfying his tax and other liabilities as required by relevant laws and regulations. This was an on-exchange active trade, i.e., a direct dealing in the secondary market.
Prior to the disposal, Zhisheng Chen's long position in WUXI BIO was 62.18 million shares, representing 1.5%; following the disposal, the holding changed to 60.98 million shares, with the long position ratio falling to 1.47%.